Drugs / Regan Tangjiang
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03089138 | Mar 2017 → Mar 2018 | — | Beijing Da-an Bio-technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Regan Tangjiang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03089138 ↗ |